SEC Form 4 · accession 0001100682-26-000107
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Birgit Girshick
Officer — Chief Executive Officer
Period of report
Jun 5, 2026
Accepted (ET)
Jun 8, 2026 · 4:21 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 5, 2026 | G | 3,386 | $0.00 | D | 36,013 | D | |
| Common StockF1 | Jun 5, 2026 | G | 3,386 | $0.00 | A | 43,803 | I | Revocable Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $208.44 | holding | — | — | — | May 31, 2025 | May 31, 2034 | Common Stock | 8,722 | 8,722 | D |
Explanation of responses
- F1Reflects the exempt transfer pursuant to Rule 16a-13 of 3,386 shares held by the reporting person to a revocable trust controlled by the reporting person.